SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased social and trading activity driven by news of its quantum-resistant technology being cited by Google researchers, alongside anticipation for US regulatory clarity. The community remains divided between long-term holders optimistic about its institutional utility and active traders debating the impact of ongoing market volatility.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly's recent FDA approval for the oral weight-loss drug Foundayo has intensified competition with Novo Nordisk, triggering active community debate over drug efficacy, side-effect profiles, and the convenience of daily pill formats versus injectables. Investors and enthusiasts are closely watching how this approval impacts long-term market share as the obesity drug sector enters a new phase of oral treatment proliferation.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is trending as investors weigh its attractive dividend yield and recent $25 billion share buyback authorization against concerns regarding heavy debt levels and ongoing service quality issues. The community is actively debating the company's turnaround potential under new leadership, with market sentiment divided between those viewing the stock as a reliable defensive play and those cautious of its long-term growth prospects.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to heightened speculation surrounding a potential buyout or major partnership, as investors track ongoing M&A activity in the weight-loss drug sector and analyze the competitive potential of VK2735 against industry leaders. The community is actively discussing the company's clinical trial progress and the perceived undervaluation of its obesity pipeline, with many members dismissing recent share price volatility as market noise in anticipation of upcoming data readouts.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trading in a volatile, highly speculative range as investors wait for a pivotal Type A meeting with the FDA regarding a Complete Response Letter (CRL) for its lead melanoma candidate, RP1. The community is sharply divided, with bulls pointing to strong clinical trial data and oncology expert support as catalysts for a potential regulatory reset, while bears cite the company's precarious cash runway, the uncertainty of a new trial design, and the historical difficulty of reversing FDA decisions.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLA Corp. is currently trending as investors weigh strong capital return initiatives, including aggressive share buybacks, against ongoing concerns regarding semiconductor sector volatility and geopolitical supply chain risks. The community remains closely divided between the bull case, centered on KLA's essential role in advanced process control for the AI roadmap, and the bear case, driven by macro uncertainty and equipment delivery headwinds.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad is capturing significant community attention as a high-performance Layer-1 blockchain, with bulls highlighting its parallel processing capabilities and high staking yields as key drivers for long-term growth despite recent volatility. Investors are actively debating the token's potential to compete with established chains, with many leveraging dips to accumulate positions while closely monitoring ecosystem integrations and network adoption.

Olin Corp. engages in the manufacturing of chemicals products. It operates through the following segments: Chlor Alkali Products and Vinyls, Epoxy, and Winchester. The Chlor Alkali Products and Vinyls segment manufactures and sells chlorine and caustic soda, ethylene dichloride and vinyl chloride monomer, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, trichloroethylene and vinylidene chloride, hydrochloric acid, hydrogen, bleach products and potassium hydroxide. The Epoxy segment produces and sells epoxy materials, which include allyl chloride, epichlorohydrin, liquid epoxy resins and downstream products such as converted epoxy resins and additives. The Winchester segment creates and sells sporting ammunition, reloading components, small caliber military ammunition and components, and industrial cartridges. The company was founded by Franklin W. Olin on August 13, 1892 and is headquartered in Clayton, MO.

Olin Corp.

Olin Corporation is trending as investors weigh its role as an essential supplier for the defense and critical minerals sectors against broader macroeconomic headwinds. The community is actively discussing the company's potential as a 'picks and shovels' play for the energy transition and military ammunition needs, with significant options activity fueling speculation about upcoming corporate events.

Almonty Industries, Inc. engages in mining, processing and shipment of tungsten concentrates. Its projects include Los Santos, Valtreixal, Almonty Korea Tungsten, Almonty Korea Moly, and Panasquiera. The company was founded on September 28, 2009 and is headquartered in Toronto, Canada.

Almonty Industries Inc

Almonty Industries is gaining attention as a key non-Chinese tungsten producer, driven by its strategic role in defense supply chains and the upcoming ramp-up of the Sangdong mine. Investors are actively tracking the firm's U.S. redomiciling efforts and potential government partnerships, which many view as long-term catalysts to counter global supply shortages.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is currently facing significant market pressure following renewed regulatory scrutiny and proposed interest rate caps on credit card debt that have sparked investor concerns regarding the broader payment ecosystem. Despite these headwinds, the community remains deeply divided, with many long-term holders treating the recent pullback as a strategic buying opportunity while others express caution over potential structural shifts in the industry.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DBX ETF Trust - Xtrackers MSCI EAFE Selection Equity ETF

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$35.45
Prev Close	$35.69
Open	$35.23
Dividend Yield	N/A
50-Day Moving Average	$36.48
Beta	N/A
Avg. Volume	3,433.32
PE Ratio	N/A

52-Week High	$38.48
52-Week Low	$27.27
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

EASG
Xtrackers MSCI EAFE Selection Equity ETF

Feed

News

Sentiment

Fundamentals

Info

Latest EASG News

EASGXtrackers MSCI EAFE Selection Equity ETF